1. An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Issue 10 (3rd October 2015) Authors: Patton, William Nigel; Lindeman, Robert; Butler, Andrew C.; Kipps, Thomas J.; Jewell, Roxanne C.; Laubscher, Kevin H.; Zhou, Yan Yan; Lewis, Eric; Sedoti, Donna; Witman, Philip; Fang, Lei; Chan, Geoffrey Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the effect of ofatumumab on cardiac repolarization. (21st August 2014) Authors: Jewell, Roxanne C.; Laubscher, Kevin; Lewis, Eric; Fang, Lei; Gafoor, Zarina; Carey, Jodi; McKeown, Astrid; West, Sarah; Wright, Oliver; Sedoti, Donna; Dixon, Iestyn; Hottenstein, Charles Scott; Chan, Geoffrey Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗